Skip to Content

PGIM Quant Solutions International Eq C PJRCX

Medalist Rating as of | See PGIM Investment Hub
  • NAV / 1-Day Return 6.79  /  −0.29 %
  • Total Assets 195.0 Mil
  • Adj. Expense Ratio
    2.690%
  • Expense Ratio 2.690%
  • Distribution Fee Level High
  • Share Class Type Level Load
  • Category Foreign Large Value
  • Investment Style Large Blend
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 2.47%
  • Turnover 111%

USD | NAV as of Apr 19, 2024 | 1-Day Return as of Apr 19, 2024, 10:18 PM GMT+0

Morningstar’s Analysis PJRCX

Will PJRCX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

The combination of a middling Process Pillar rating and a Below Average People Pillar rating limit PGIM Quant Solutions International Eq C to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings PJRCX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 13.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Taiwan Semiconductor Manufacturing Co Ltd

2.66 5.4 Mil
Technology

Novo Nordisk A/S Class B

2.18 4.4 Mil
Healthcare

Prudential Govt Money Mkt Fd

1.57 3.2 Mil
Cash and Equivalents

iShares MSCI EAFE ETF

1.46 3.0 Mil

ASML Holding NV

1.30 2.6 Mil
Technology

Novartis AG Registered Shares

1.23 2.5 Mil
Healthcare

Shell PLC

1.12 2.3 Mil
Energy

Siemens AG

1.04 2.1 Mil
Industrials

Hermes International SA

0.94 1.9 Mil
Consumer Cyclical

GSK PLC

0.92 1.9 Mil
Healthcare